RACHEL ZSIGA: Open Payments
NPI 1144509050 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 27 payments from 14 companies in 2025. Trend: 2023 $1,976 · 2024 $510 · 2025 $588
Food & beverage: $520Education: $68
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $86 |
| Boston Scientific Corporation | 4 | $76 |
| Sumitomo Pharma America, Inc. | 4 | $68 |
| Endo USA, Inc. | 3 | $68 |
| PFIZER INC. | 2 | $51 |
| BIOPROTECT MEDICAL, INC. | 2 | $47 |
| ACCORD HEALTHCARE, INC. | 2 | $41 |
| Medtronic, Inc. | 2 | $39 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
| 180 Medical, Inc. | 1 | $21 |
Products named: Xtandi, GEMTESA, XIAFLEX, BIOPROTECT BALLOON IMPLANT SYSTEM, Camcevi, INTERSTIM, AMS 700, JOURNAVX.
Industry payments across OK — which companies pay providers there.
